35486611000001102: Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB)
\UK product\Virtual medicinal product\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram conventional release eye ointment\Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB)
\UK product\Virtual therapeutic moiety\Betamethasone\Product containing only betamethasone in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram conventional release eye ointment\Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB)
\UK product\Virtual therapeutic moiety\Betamethasone\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram conventional release eye ointment\Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB)

\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing betamethasone\Betamethasone\Product containing only betamethasone in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram conventional release eye ointment\Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing betamethasone\Betamethasone\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram conventional release eye ointment\Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing betamethasone\Product containing betamethasone in ocular dose form (medicinal product form)\Product containing only betamethasone in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram conventional release eye ointment\Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing pregnane\Product containing betamethasone\Betamethasone\Product containing only betamethasone in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram conventional release eye ointment\Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing pregnane\Product containing betamethasone\Betamethasone\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram conventional release eye ointment\Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing pregnane\Product containing betamethasone\Product containing betamethasone in ocular dose form (medicinal product form)\Product containing only betamethasone in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram conventional release eye ointment\Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing corticosteroid and/or corticosteroid derivative (product)\Product containing fluorinated corticosteroid\Product containing betamethasone\Betamethasone\Product containing only betamethasone in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram conventional release eye ointment\Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing corticosteroid and/or corticosteroid derivative (product)\Product containing fluorinated corticosteroid\Product containing betamethasone\Betamethasone\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram conventional release eye ointment\Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing corticosteroid and/or corticosteroid derivative (product)\Product containing fluorinated corticosteroid\Product containing betamethasone\Product containing betamethasone in ocular dose form (medicinal product form)\Product containing only betamethasone in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram conventional release eye ointment\Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing corticosteroid and/or corticosteroid derivative (product)\Product containing glucocorticoid\Product containing betamethasone\Betamethasone\Product containing only betamethasone in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram conventional release eye ointment\Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing corticosteroid and/or corticosteroid derivative (product)\Product containing glucocorticoid\Product containing betamethasone\Betamethasone\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram conventional release eye ointment\Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB)
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing corticosteroid and/or corticosteroid derivative (product)\Product containing glucocorticoid\Product containing betamethasone\Product containing betamethasone in ocular dose form (medicinal product form)\Product containing only betamethasone in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram conventional release eye ointment\Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB)
\Medicinal product\Product manufactured as ocular dose form\Product containing betamethasone in ocular dose form (medicinal product form)\Product containing only betamethasone in ocular dose form (medicinal product form)\Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram conventional release eye ointment\Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 13-Jun 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

107104101000001114 Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

107104201000001119 Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB)	VMP non-availability indicator	Not available	true	Inferred relationship	Existential restriction modifier
Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB)	Is a	Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram conventional release eye ointment	true	Inferred relationship	Existential restriction modifier
Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB)	Has active ingredient	Betamethasone sodium phosphate	false	Inferred relationship	Existential restriction modifier
Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB)	Has manufactured dose form	Conventional release eye ointment	true	Inferred relationship	Existential restriction modifier
Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB)	VMP non-availability indicator	Available	false	Inferred relationship	Existential restriction modifier
Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB)	Has specific active ingredient	Betamethasone sodium phosphate	true	Inferred relationship	Existential restriction modifier
Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB)	Has dispensed dose form	Conventional release eye ointment	true	Inferred relationship	Existential restriction modifier
Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB) 3 gram	Has AMP	True	Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
107104101000001114	Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
107104201000001119	Betamethasone 0.1% eye ointment (RPH Pharmaceuticals AB)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module